Spirogen Ltd.
29-39 Brunswick Square
London
United Kingdom
Tel: +44-(0)-207-278-0555
Website: http://www.spirogen.com/
Email: info@spirogen.com
6 articles with Spirogen Ltd.
-
AstraZeneca PLC's MedImmune Takes Over Spirogen Ltd. for Up to $400 Million to Bolster Oncolology Portfolio
10/15/2013
-
Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer
4/8/2013
-
Ablynx and Spirogen Ltd. Enter Into a Research Collaboration to Evaluate the Potential of Novel Toxin-Nanobody Drug Conjugates in Cancer
2/25/2013
-
PolyTherics Announces a Research Collaboration With Spirogen Ltd. to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012
-
PolyTherics and Spirogen Ltd. Announce a Research Collaboration to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012
-
Spirogen Ltd. Announces a Research Collaboration and License Agreement with Spirogen Ltd. for the Discovery and Development of Antibody Drug Conjugates
1/6/2011